Michael P Morrissey
Michael P Morrissey
Head, Oncology Genomics and Analytics, Merck Research Laboratories
Verified email at merck.com
Title
Cited by
Cited by
Year
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ...
Nature 483 (7391), 603, 2012
50792012
Next-generation characterization of the Cancer Cell Line Encyclopedia
M Ghandi, FW Huang, J Jané-Valbuena, GV Kryukov, CC Lo, ...
Nature 569 (7757), 503, 2019
5012019
Interfering with resistance to smoothened antagonists by inhibition of the PI3K pathway in medulloblastoma
S Buonamici, J Williams, M Morrissey, A Wang, R Guo, A Vattay, K Hsiao, ...
Science translational medicine 2 (51), 51ra70-51ra70, 2010
4302010
Pharmacological and genomic profiling identifies NF-κB–targeted treatment strategies for mantle cell lymphoma
R Rahal, M Frick, R Romero, JM Korn, R Kridel, FC Chan, B Meissner, ...
Nature medicine 20 (1), 87, 2014
2782014
Identification of cervical cancer markers by cDNA and tissue microarrays
Y Chen, C Miller, R Mosher, X Zhao, J Deeds, M Morrissey, B Bryant, ...
Cancer research 63 (8), 1927-1935, 2003
2072003
Pharmacogenomic agreement between two cancer cell line data sets
TGDSC Consortium, The Cancer Cell Line Encyclopedia Consortium
Nature 528, 84-87, 2015
200*2015
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
EJ Orlando, X Han, C Tribouley, PA Wood, RJ Leary, M Riester, JE Levine, ...
Nature medicine 24 (10), 1504, 2018
1572018
Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism
GM Mirzaa, CD Campbell, N Solovieff, CP Goold, LA Jansen, S Menon, ...
JAMA neurology 73 (7), 836-845, 2016
1522016
Association of MTOR mutations with developmental brain disorders, including megalencephaly, focal cortical dysplasia, and pigmentary mosaicism
K Campbell, N Solovieff, M Morrissey, R Leary, S Mahan, W Adamovich, ...
JAMA Neurology 73 (7), 836-845, 2016
1502016
Evidence for the role of PrPC helix 1 in the hydrophilic seeding of prion aggregates
MP Morrissey, EI Shakhnovich
Proceedings of the National Academy of Sciences 96 (20), 11293-11298, 1999
1481999
Contribution of polycomb homologues Bmi-1 and Mel-18 to medulloblastoma pathogenesis
D Wiederschain, L Chen, B Johnson, K Bettano, D Jackson, J Taraszka, ...
Molecular and cellular biology 27 (13), 4968-4979, 2007
1282007
The Cancer Cell Line Encyclopedia-Using Preclinical Models to Predict Anticancer Drug Sensitivity
J Barretina, G Caponigro, N Stransky, K Venkatesan, AA Margolin, S Kim, ...
EUROPEAN JOURNAL OF CANCER 48, S5-S6, 2012
95*2012
The Polycomb group protein Bmi-1 is essential for the growth of multiple myeloma cells
Z Jagani, D Wiederschain, A Loo, D He, R Mosher, P Fordjour, ...
Cancer research 70 (13), 5528-5538, 2010
802010
Design of proteins with selected thermal properties
MP Morrissey, EI Shakhnovich
Folding and design 1 (5), 391-405, 1996
731996
METHODS FOR THE IDENTIFICATION, ASSESSMENT, AND TREATMENT OF PATIENTS WITH PROTEASOME INHIBITION THERAPY
G MULLIGAN, B BRYANT, M MORRISSEY, A BOLT, A DAMOKOSH
WO Patent 2,004,053,066, 2004
562004
NUCLEIC ACID MOLECULES AND PROTEINS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND THERAPY OF OVARIAN CANCER
J MONAHAN, M GANNAVARAPU, S HOERSCH, S KAMATKAR, ...
WO Patent 2,002,071,928, 2002
552002
Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy
G Mulligan, B Bryant, M Morrissey, A Bolt, A Damokosh
US Patent App. 10/728,055, 2004
542004
Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy
G Mulligan, B Bryant, M Morrissey, A Bolt, A Damokosh
US Patent App. 10/728,055, 2004
532004
Methods for the identification, assessment, and treatment of patients with proteasome inhibition therapy
G Mulligan, B Bryant, M Morrissey, A Bolt, A Damokosh
US Patent App. 10/728,055, 2004
532004
PureCN: copy number calling and SNV classification using targeted short read sequencing
DYCMPM Markus Riester, Angad P. Singh, A. Rose Brannon, Kun Yu, Catarina D ...
Source Code for Biology and Medicine 11 (13), 2016
432016
The system can't perform the operation now. Try again later.
Articles 1–20